|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/28 |
| (11) | Patento numeris | 2408816 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10708688.6 |
| Europos patento paraiškos padavimo data | 2010-03-16 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-01-25 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-09-04 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2010/027422 |
| Data | 2010-03-16 |
| (87) | Numeris | WO 2010/107752 |
| Data | 2010-09-23 |
| (30) | Numeris | Data | Šalis |
| 162154 P | 2009-03-20 | US | |
| 306829 P | 2010-02-22 | US |
| (72) |
HSU, Hailing, US
FOLTZ, Ian, CA
ARORA, Taruna, US
JACOBSEN, Frederick, W., US
|
| (73) |
Amgen Inc.,
Law Department One Amgen Center Drive, Thousand Oaks, CA 91320,
US
|
| (54) | ALPHA-4-BETA-7 HETERODIMER SPECIFIC ANTAGONIST ANTIBODY |
| ALPHA-4-BETA-7 HETERODIMER SPECIFIC ANTAGONIST ANTIBODY |